Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Deadline Reprieve Mooted For Russian Registration Replacements

Executive Summary

Medtech companies are being warned that if they do not renew their registration certificates in Russia by the start of 2017, their certificates will become invalid.

You may also be interested in...



Flurry of Russian Medtech Regulatory System Proposals Keeps Manufacturers On Their Toes

Russian medtech industry expert Alexey Stepanov reports an uptick in regulatory activity nationally in the final trimester of 2016. The catalyst seems to be the impending launch of the system of harmonization of medical device regulation within the regional Eurasian Economic Union (EAEU).

Eurasian Medtech System Battles To Be In Place This Year

The Eurasian Economic Union's system for regulating medtech products is dropping into place, but too slowly as some see it, and still with many questions remaining over the content. However, it remains a fixture for the future, and device companies serving the region need to be prepared.

INTERVIEW: Russia opts for strict approach in evolving regulatory landscape

The government of Russia is in the midst of developing a system that will regulate medical devices properly for the first time. A mix of former Soviet and modern day concepts, it errs more towards the US FDA than the EU approach. But there are major business opportunities among the challenges, Alexandra Tretiakova, executive director of Moscow-based medical devices association IMEDA, tells Ashley Yeo

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103869

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel